Introduction
IL-2 is a regulator of cell cycle progression in T lymphocytes (Smith, 1984 ) that binds to a speci®c cell surface receptor composed of three distinct subunits, a,b and g or p55, p70 and p64, respectively (Leonard et al., 1984; Nikaido et al., 1984; Cosman et al., 1984; Hatakeyama et al., 1989; Takeshita et al., 1992) .
Expression of the bcl-2 proto-oncogene is associated with the suppression of apoptosis (Miyazaki et al., 1995; NunÄ ez et al., 1990 NunÄ ez et al., , 1994 Wyllie, 1995; Korsmeyer, 1992; Collins and Rivas, 1993; Weller et al., 1995; Schwartz and Osborne, 1993) . Bcl-2 is located mainly in the outer membrane of mitochondria and also in the nuclear envelope and parts of the endoplasmic reticulum (Chen et al., 1989; Monaghan et al., 1992; Krajewski et al., 1993; De Jong et al., 1994) . Bcl-2 is constitutively expressed in IL-3-dependent cells and its expression decreases when cells are deprived of IL-3 and undergo apoptosis. Overexpression of Bcl-2 in IL-3-dependent cells extends cell survival time in the absence of IL-3 (Vaux et al., 1988 , Rinaudo et al., 1995 . IL-2-dependent T cells also die by apoptosis after IL-2 withdrawal and transfection of Bcl-2 promotes survival in the absence of IL-2 (Broome et al., 1995a,b; Podack, 1993, GoÂ mez et al., 1996; Minami and Taniguchi, 1995; Miyazaki et al., 1995) . In addition, IL-2R common g chain signalling cytokines regulate apoptosis in response to growth factor deprivation by induction of Bcl-2 (Akbar et al., 1996) . Bcl-2 is also an important regulator of the survival of sympathetic neurons after nerve growth factor deprivation (Greenlund et al., 1995; Merry and Korsmeyer, 1997) . Expression of the Bcl-2 transgene provides T cells with improved survival capacities under de®cient or stressful culture conditions (Strasser et al., 1991; Katsumata et al., 1992; Sentman et al., 1991) . In addition, this transgenic model indicates that multiple death pathways operate within the thymus that can be distinguished by their dependence on Bcl-2.
Recent studies have described a variety of stimuli that regulate the levels of bcl-2 mRNA or proteins, such as IL-6, IL-10, INF-g transforming growth factor-b (TGF-b, some viral proteins, retinoids, nerve growth factor and phorbol esters (Hanada et al., 1993; Makover et al., 1991; Reed et al., 1987; Selvakumaran et al., 1994; Katoh et al., 1997; Cohen et al., 1997; Sekiya et al., 1997) . Stimulation of human peripheral blood lymphocytes with phorbol ester or phorbol ester and IL-2 causes accumulation of Bcl-2a and b mRNA (Henderson et al., 1991) .
Some of the transcription factors controlling T cell activation and dierentiation, such as NK-kB, AP-1 and Oct-1 (Ivanov et al., 1995) , may participate in controlling apoptosis through regulation of Bcl-2 expression. It has been shown that Bcl-2 suppresses apoptosis resulting from disruption of the NF-kB survival pathway (Herrmann et al., 1997) . Maximal induction of many T cell cytokine genes requires cell treatment with both calcium ionophores and phorbol esters, suggesting the necessity for both calcium-and PKC-dependent pathways for cytokine production .
Here we have characterized the role of NF-AT in the control of Bcl-2 expression. As for several other transcription factors, NF-AT activity appears to be regulated by subcellular localization and phosphorylation events (Clipstone and Crabtree, 1992) and by interactions between calcineurin and Bcl-2 (Shibasaki et al., 1997) . NF-AT is composed of the transcription factor AP-1 and a cytoplasmic subunit, the latter encoded by a family of genes including NFATp, NF-ATc, NF-AT3 and NF-AT4/x Masuda et al., 1995; Northrop et al., 1994) . The family members share approximately 70% sequence identity within a region related to the Rel homology domain of the NF-kB transcription factors Northrop et al., 1994) . Most NF-AT sites are composite elements that also contain AP-1 binding sites (Rao, 1994; Rooney et al., 1995) and are calciumand PKC-inducible. Thus, these sites represent a composite binding site allowing for combinatorial interaction between two dierent classes of transcription factors (Miner and Yamamoto, 1991) . The immunosuppressive drug cyclosporin A (CsA) inhibits phosphatase calcineurin (CN), preventing activation of transcription factor NF-AT (Mattila et al., 1990; Emmel et al., 1989; Randak et al., 1990; Flanagan et al., 1991) . Using the IL-2-, IL-4-or IL-9-dependent murine T cell line TS1ab, we studied the mechanisms controlling Bcl-2 expression. We show that bcl-2 mRNA or protein levels are downregulated by IL-4 and upregulated by IL-2. IL-4 also inhibits DNA binding activity of the transcription factors AP-1, NF-AT and SP-1. IL-2-induced DNA binding activity of these factors is sensitive to the phosphatidylinositol 3 kinase (PI3 K) inhibitor wortmannin and to the Rho inhibitor Clostridium dicile toxin B. Bcl-2 expression is blocked by calcineurin inhibitors and upregulated by constitutive calcineurin expression. Moreover, a dominant negative NF-AT expression vector downregulates Bcl-2 expression in IL-2-stimulated cells. The implications of the dierential regulation of Bcl-2 expression by IL-2 and IL-4 are discussed.
Results

IL-4 induces Bcl-2 downregulation in TS1ab cells
TS1ab cells proliferate in the presence of IL-2, IL-4 or IL-9 (Pitton et al., 1993) . TS1ab cells maintained in IL-2, but not in IL-4, express Bcl-2 ( Figure 1a ). To determine whether IL-4 would be able to modulate Bcl-2 expression, IL-2-maintained cells were stimulated with IL-4 or with a mixture of IL-2 and IL-4. Also, IL-4-maintained cells were stimulated with IL-2 or the mixture of IL-2 and IL-4 and Bcl-2 expression was analysed in Western blot. Under all conditions tested, IL-2 stimulation always triggered Bcl-2 expression ( Figure 1a) . Similarly, the IL-4-dependent murine T cell line LD8 does not express Bcl-2 and the IL-2-dependent murine T cell line CTLL-2 expresses Bcl-2 (data not shown).
To determine whether IL-4 diminishes the IL-2-dependent signal or delivers a negative signal that downregulates Bcl-2 expression, IL-2-cultured TS1ab cells were stimulated with IL-4 or deprived of IL-2 and Bcl-2 expression analysed in Western blot. IL-4-induced downregulation of Bcl-2 expression is more pronounced than that caused by lymphokine deprivation (Figure 1b) . Ten hours after IL-4 stimulation, Bcl-2 expression is undetectable, while cells cultured for the same period in IL-2-deprived medium still show Bcl-2 expression. The same blot was stripped and probed with anti-Ras antibody as an internal control of protein loading. These results suggest that IL-4 negatively controls Bcl-2 expression and that the positive signal delivered by IL-2 is dominant over the negative signal provided by IL-4.
Since TS1ab cells do not express Bcl-2 in the presence of IL-4, we inquired whether this lymphokine modulates Bcl-2 mRNA levels. mRNA was isolated Figure 1 (a) Regulation of Bcl-2 expression by IL-2 and IL-4 in IL-2-or IL-4-stimulated cells. TS1ab cells were stimulated by IL-2 (5 ng/ml) and IL-4 (60 U/ml) and then switched from IL-2 to IL-4 (60 U/ml) (1); from IL-4 to IL-2 (5 ng/ml) (2); from IL-2 to IL-2+IL-4 (5 ng/ml+60 U/ml) (3) or from IL-4 to IL-4+IL-2 (60 U/ml+5 ng/ml) (4). At 24, 72, 96 and 120 h, cells were harvested and lysed as described in Materials and methods. Protein extracts were separated in SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bcl-2 antibody. Cells maintained in IL-2 (5 ng/ml) or IL-4 (60 U/ml) were used as positive or negative control for Bcl-2 expression respectively. Protein bands were detected using the ECL system. Protein loading was adjusted to total number of cells. Similar results were obtained in three independent experiments. Molecular markers are shown. Lane 1, IL-2 growing cells transferred to IL-4-containing medium; lane 2, IL-4 growing cells transferred to IL-2-containing medium; lane 3, IL-2 growing cells transferred to IL-2+IL-4-containing medium; lane 4, IL-4 growing cells transferred to IL-4+IL-2-containing medium. (b) Downregulation of Bcl-2 expression by IL-4 stimulation or lymphokine deprivation. TS1ab cells (2610 6 ) were stimulated by IL-4 (60 U/ ml) or lymphokine-deprived. At 2, 4, 6, 8 and 10 h, cells were lysed as described in Materials and methods. Protein extracts were separated in SDS/PAGE, transferred to nitrocellulose and probed with anti-Bcl-2 antibody. Cells maintained in IL-2 were used as positive control. Protein bands were detected using the ECL system. The same blot was stripped and reprobed with anti-Ras antibody as an internal control of protein loading. Similar results were obtained in three independent experiments. Molecular markers are shown from IL-2-or IL-4-stimulated cells growing either in IL-2 or IL-4. The results clearly show that IL-4 and IL-2 down-and upmodulate, respectively, the relative Bcl-2 mRNA levels ( Figure 2 ). Forty-eight hours after IL-2 stimulation, IL-2 positively modulates Bcl-2 mRNA levels, whereas IL-4 negatively modulates its expression. These levels are regulated with similar kinetics to those of the appearance of Bcl-2 protein.
The b-actin levels were similar in all cases.
Dierential transcriptional activation triggered by IL-4 and IL-2
To investigate how IL-4 might inhibit Bcl-2 expression, we examined the DNA binding activity of several transcription factors important for T cell activation and proliferation. Nuclear extracts were isolated, protein concentration determined and DNA-nuclear protein interactions were monitored in an electrophoretic mobility shift assay. DNA binding activity for AP-1, NF-AT and SP-1 was detected in IL-2, but not in IL-4 cultured cells, while CREB, Oct-1 and NF-kB binding activity was equal in IL-4-and IL-2-cultured cells ( Figure 3a ). The two speci®c AP-1 bands correspond to dierent Jun/Fos homo and heterodimers.
When IL-4-cultured cells are further stimulated by IL-2 for 48 h, activation of AP-1, NF-AT and SP-1 takes place. When IL-2-cultured cells are further activated by IL-4 for 48 h, they show a partial decrease in AP-1 and SP-1 DNA binding activity and total inhibition in NF-AT DNA binding activity. Oct-1 and CREB binding activity are not aected and NF-kB activation is slightly decreased in IL-4-stimulated cells. Speci®c bands are marked with arrows. Speci®c DNA-nuclear protein interaction was con®rmed by competition with the appropriate unlabelled oligonucleotide (data not shown). These data suggest that switching of cells from IL-2 to IL-4 partially inhibits AP-1 and SP-1 activation and completely blocks NF-AT transcription factor activation compared to control IL-2-cultured cells. In addition, as analysed by Western blot, TS1ab cells maintained in IL-2, but not in IL-4, express the NF-AT family member NF-ATp (Figure 3b ).
Clostridium dicile toxin B and wortmannin regulate IL-2-triggered nuclear factors in TS1ab cells
We have shown that IL-2 induces Bcl-2 expression by activating RhoA, PI3 K and protein kinase C (PKC) (GoÂ mez et al., 1997a) . IL-2-promoted Bcl-2 expression is inhibited by the speci®c Rho family inhibitor Clostridium dicile toxin B and by the PI3 K and PKC inhibitors wortmannin and GF109203X, respectively (GoÂ mez et al., 1997b) . To determine whether inhibition of some steps in the Bcl-2 expression pathway modi®es IL-2-induced activation of NF-kB, SP-1, AP-1, Oct-1, NF-AT and CREB, TS1ab cells were grown in IL-2 and treated for 24 h with C. dicile toxin B or wortmannin. Nuclear extracts were prepared, protein concentration determined, and DNA-nuclear protein interactions were detected by electrophoretic mobility shift assays.
SP-1, NF-AT, NF-kB and AP-1 DNA-binding activities are sensitive to the inhibition of PI3 K activity by wortmannin (Figure 4a ), while CREB and Oct-1 binding activity were unaltered. Toxin B also inhibits SP-1, NF-AT, NF-kB and AP-1 activation and does not modify CREB and Oct-1 activity. When IL-4-stimulated cells are further activated by IL-2 for 48 h, they show AP-1, SP-1 and NF-AT DNA binding activity. Speci®c bands are marked with arrows. The speci®city of DNA-nuclear protein interactions was con®rmed by competition with the appropriate unlabelled oligonucleotide (data not shown). These results show a probable correlation between DNA-binding activity of NF-AT, AP-1 and SP-1 and the signalling pathway that controls IL-2-induced Bcl-2 expression.
The pattern of Bcl-2 expression was determined in IL-2-stimulated cells treated with several concentrations of the Rho or PI3 K inhibitors toxin B or wortmannin, respectively. Figure 4b shows the dosedependent inhibition of Bcl-2 expression by toxin B and wortmannin. Even the lowest concentration of the inhibitors induces a remarkable decrease in Bcl-2 expression when compared to IL-2 cultured control cells.
Role of NF-AT transcription factor in the control of Bcl-2 expression As IL-4-stimulated TS1ab cells are unable to trigger NF-AT activation, we further characterized the role of NF-AT in Bcl-2 expression. The ability of NF-AT to activate transcription in TS1ab cells was tested using three copies of an NF-AT binding site upstream of a minimal promoter linked to the luciferase reporter gene. Transient cotransfection of pHook3 and 3XN-FAT/Luc in IL-2-stimulated TS1ab cells resulted in a 15-fold increase in reporter gene activation compared to a control transfection with an irrelevant plasmid Figure 2 Bcl-2 mRNA expression in IL-2-or IL-4-stimulated cells. Total RNA was isolated from IL-2-or IL-4-activated cells (5 ng/ml or 60 U/ml respectively). RNA (15 mg) was electrophoresed in 1% agarose in the presence of formaldehide, blotted and hybridized at high stringency with a 32 P-labelled DNA probe EcoRI ± HindIII of 800 bp for Bcl-2. After elution of this probe, the blot was rehybridized with a 32 P-labelled probe ClaI ± BamHI of 600 bp for b-actin. DNA probes were labelled by random priming. Data are representative of three independent experiments ( Figure 5) . In IL-4-stimulated TS1ab cells, pHook3 and 3XNF-AT/Luc cotransfection only resulted in a 1.6-fold increase in reporter gene activation. This result suggests that IL-2 induces NF-AT transcriptional activation of the luciferase reporter gene under these experimental conditions.
The immunosuppressive drugs CsA and FK506 inhibit calcineurin activity, preventing the nuclear localization of NF-AT. We previously showed that CsA and FK506 inhibit NF-AT DNA-binding activity in IL-2-stimulated TS1ab cells (Rebollo et al., 1995) . As this activity is also inhibited by IL-4, we asked whether this transcription factor could be responsible for Bcl-2 expression control. IL-2-stimulated cells were treated with FK506 or CsA and time-dependent downregulation of Bcl-2 expression was analysed ( Figure 6 ). Twenty-four hours after FK506 treatment, Bcl-2 expression is inhibited and its expression is also downregulated 6 h after CsA treatment. The blot was stripped and probed with anti-Ras antibody as an internal control of protein loading. These results demonstrate that NF-AT directly or indirectly controls Bcl-2 expression.
Since NF-AT inhibition downregulates Bcl-2 expression, a constitutively active calcineurin mutant might induce its expression in IL-4-stimulated cells. TS1ab cells transfected with a constitutively active calcineurin mutant or an irrelevant vector were stimulated with IL-4 and Bcl-2 expression determined in Western blot (Figure 7) . IL-2-or IL-4-stimulated cells were used as positive and negative control for Bcl-2 expression, respectively. Upon stimulation by IL-4, cells transfected with a constitutively active calcineurin mutant show Bcl-2 expression, whereas mock transfectants or cells transfected with an irrelevant vector do not upregulate Bcl-2 expression. The blot was stripped and probed with anti-Ras antibody as an internal control of protein loading.
To characterize the extent to which NF-AT controls Bcl-2 expression, transiently transfected cells with a dominant negative NF-AT expression vector were Figure 3 (a) Eect of IL-2 and IL-4 on the induction of nuclear factor activities. Nuclear proteins were isolated from IL-2 (5 ng/ml) or IL-4 (60 U/ml)-activated 1610 7 cells. Similarly, nuclear proteins were isolated from IL-2 cultured cells transferred to IL-4-containing medium for 48 h and vice-versa. After quanti®cation, 3 mg of nuclear proteins were incubated with the indicated 32 P-end labelled oligonucleotide. Protein-DNA complexes were separated from free oligonucleotide in 5% polyacrylamide gels and then dried and exposed to X-ray ®lm. The speci®city for each site was tested using 20-fold molar excess of speci®c cold oligonucleotide. P-labelled oligonucleotide. Protein-DNA complexes were separated from free oligonucleotide in 5% polyacrylamide gels and then dried and exposed to X-ray ®lm. The speci®city for each site was tested using 20-fold molar excess of speci®c cold oligonucleotides. Speci®c bands are marked by arrows. Similar results were obtained in three independent experiments. (b) Eect of Rho and PI3 K inhibitors on Bcl-2 expression. Cells cultured in the presence of IL-2 were supplemented with dierent concentrations of Toxin B or Wortmannin. After treatment, cells were lysed and protien extracts separated by SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bcl-2 antibody. Cells maintained in the presence of IL-2 were used as positive control for Bcl-2 expression. Protein bands were detected using the ECL system. The blot was probed with anti-Ras antibody as an internal control of protein loading. Similar results were obtained in three independent experiments Figure 5 Eect of IL-2 on transactivation by NF-AT binding sites. TS1ab cells (1610 7 ) were transiently cotransfected with pHook3, which express a hapten-speci®c single chain antibody, and 3XNF-AT-Luc containing three copies of the NF-AT site from the IL-2 promoter or an irrelevant plasmid (pCMV4-Hp55). After transfection, cells were stimulated for 24 h with 5 ng/ml of IL-2 or 60 U/ml of IL-4, collected, washed, separated from untransfected cells using magnetic beads coated with phOX hapten and assayed for luciferase activity as described in Materials and methods. Similar results were obtained in three independent experiments Control of Bcl-2 expression by IL-2 and IL-4 J Go Â mez et al tively. Bcl-2 expression is also downregulated by inhibition of the calcium/calmodulin-dependent phosphatase calcineurin. Constitutive expression of this phosphatase upregulates Bcl-2 expression in IL-4-stimulated cells. Finally, expression of a dominant negative NF-AT mutant downregulates Bcl-2 expression in IL-2-stimulated cells. Our results suggest that NF-AT transcription factor is directly or indirectly involved in the control of Bcl-2 expression.
We observed previously that Rho suppresses apoptosis through Bcl-2 induction in lymphokinedeprived TS1ab cells, and this mechanism is probably responsible for IL-2-promoted TS1ab cell survival (GoÂ mez et al., 1997b) . In this system, IL-2 deprivation resulted in a gradual disappearance of Bcl-2, as also occurs when cells are stimulated with IL-4. Since IL-4 downregulates Bcl-2 expression (Figure 1 ) more rapidly than does IL-2 deprivation, IL-4 may either diminish IL-2-dependent signals or deliver a negative signal that downregulates Bcl-2. Our results strongly suggest that IL-4 gives a negative signal, but additional levels of control can not be ruled out. In fact, regulation of Bcl-2 expression is also mediated by IL-6, TGF-b, retinoids, phorbol esters and some viral proteins (Hanada et al., 1993; Makover et al., 1991; Reed et al., 1987; Henderson et al., 1991) .
We previously showed dierences between signal transduction events triggered by IL-2 or IL-4 stimulation (GoÂ mez et al., 1995a; . Few IL-4-stimulated signalling mechanisms have been identi®ed. Both IL-2 and IL-4 promote CREB, Oct-1 and NF-kB activation, whereas NF-AT, SP-1 and AP-1 show DNA binding activity only in IL-2-cultured cells. It is interesting to notice the dierent mobility of NF-kB in IL-4-cultured cells, which suggest probably changes in the NF-kB family member complexes. AP-1 activity is induced upon switching from IL-4 to IL-2, and residual activity remains when switching from IL-2 to IL-4. Still both IL-2-and IL-4-stimulated Ts1ab cells express c-jun and c-fos (data not shown) suggesting that AP-1 DNA binding activity could be due to the dierential expression of other members of the Jun or Fos families, or to posttranslational modi®cation of Jun or Fos proteins, such as phosphorylation by Jun kinases (JNK). None of the transcription factors tested is speci®cally induced by IL-4 (Figure 3) . The three transcription factors activated speci®cally in IL-2-cultured cells are wortmannin-and toxin B-sensitive (Figure 4 ), suggesting that PI3 K and Rho proteins drive a speci®c IL-2 signalling pathway that results in their activation. NF-AT is the transcription factor most strongly inhibited by IL-4. Treatment of cells with FK506 or CsA, which blocks calcineurin and inhibits IL-2-induced NF-AT activity (Rebollo et al., 1995) , downregulates IL-2-induced Bcl-2 expression. In accordance with these results, constitutive expression of this phosphatase upregulates Bcl-2 expression. In addition, expression of a NF-AT dominant 1610 7 ) were transiently transfected with an irrelevant plasmid (pCMV4-Hp55) or three dierent concentrations of a constitutively active calcineurin mutant (1.5, 2.5 or 5 mg) by the DEAE-dextran method and stimulated by IL-4 (60 U/ml). Twenty-four hours after transfection, protein extracts were separated in SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bcl 2 antibody as described in Materials and methods. IL-2-or IL-4-activated cells (5 ng/ml or 60 U/ml respectively) were used as positive and negative Bcl-2 expression controls, respectively. Protein bands were developed using the ECL system. The membrane was stripped and reprobed with anti-Ras antibody as an internal control of protein loading. Similar results were obtained in three independent experiments. Molecular markers are shown 1610 7 ) were transiently cotransfected with pHook3 and a NF-AT dominant negative mutant by the DEAE-dextran method and stimulated by IL-4 (60 U/ml) or IL-2 (5 ng/ml) for 24 h. After transfection, cells were washed, separated from untransfected cells as described in Materials and methods and lysed. Protein extracts were separated in SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bcl-2 antibody. IL-2-or IL-4-cultured cells were used as positive and negative Bcl-2 expression control, respectively. Protein bands were developed using the ECL system. The membrane was stripped and reprobed with anti-Ras antibody as an internal control of protein loading. Similar results were obtained in three independent experiments. Molecular markers are shown Figure 6 Eect of calcineurin inhibitors CsA and FK506 on IL-2-induced Bcl-2 expression. IL-2-stimulated cells (2610 6 ) were supplemented with 10 ng/ml of CsA or 20 ng/ml of FK506 for 6, 12 and 24 h. After treatment, cells were lysed and protein extracts separated in SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bcl-2 antibody as described in Materials and methods. Cells maintained in IL-2 (5 ng/ml) were used as positive control for Bcl-2 expression. Protein bands were detected using the ECL system. The blot was stripped and probed with anti-Ras antibody as an internal control of protein loading. Similar results were obtained in three independent experiments. Molecular markers are shown Control of Bcl-2 expression by IL-2 and IL-4 J Go Â mez et al negative mutant also downregulates Bcl-2 expression. It has been also reported that Bcl-2 forms a tight complex with calcineurin, resulting in the targeting of calcineurin to Bcl-2 sites on cytoplasmic membranes (Shibasaki et al., 1997) . In addition, Bcl-2 impairs NF-AT mediated transactivation (Linette et al., 1996) . The dierential DNA binding activity of NF-AT in IL-2-or IL-4-stimulated TS1ab cells might be explained by the fact that the PKC implicated in the IL-2 response is not involved in signaling through the IL-4 receptor GoÂ mez et al., 1994 GoÂ mez et al., , 1995 , and IL-4-stimulated TS1ab cells therefore do not express Bcl-2.
These observations demonstrate that NF-AT is directly or indirectly involved in Bcl-2 expression through an IL-2-stimulated signal transduction pathway involving Rho, PI3 K and PKC, and identify calcineurin as a signalling enzyme in the control of NF-AT (GoÂ mez et al., 1997a) .
It has been claimed that NF-AT induction is the pivotal event in the activation of immediate and early T cell speci®c genes . Based on these results and on the three-channel model proposed for IL-2-dependent proliferation (Miyazaki et al., 1995; Rebollo et al., 1996) , it is tempting to speculate that NF-AT plays a key role in the early induction of Bcl-2 expression, which is required for IL-2-but not IL-4-dependent proliferation. Our results could also support the hypothesis of an indirect control of Bcl-2 expression by NF-AT through an intermediary protein or by triggering the expression of a secondary transcription factor. In NF-ATp-de®cient mice, the splenomegaly and increased lymphocyte proliferation observed suggest a function for this transcription factor in regulating cell proliferation and/or apoptosis (Hodge et al., 1996; Liu et al., 1991; Ru and Leach, 1995; Shaw et al., 1995) .
The mechanism of signal transduction through the IL-4 receptor is still not clearly de®ned. Most IL-2-activated signalling mediators are either insensitive to IL-4 stimulation or their activation is irrelevant for cell proliferation and survival . The only transducing molecules putatively associated to IL-4 receptor signalling mechanisms are the insulin receptor substrate (IRS)-related proteins, which upon phosphorylation act as multidocking sites for signalling proteins with SH2 domains (Hodge et al., 1996; Sun et al., 1991 Sun et al., , 1995 . The lack of Bcl-2 expression in IL-4-stimulated cells is reminiscent of the disappearance of Bcl-2 in IL-2-deprived TS1ab cells, which are committed to die by apoptosis. However, IL-4-stimulated cells survive and proliferate in longterm culture. This is due to the fact that Bcl-x is constitutively expressed in TS1ab cells under any culture conditions (GoÂ mez et al., 1997c) , indicating that it may be sucient to account for IL-4-promoted cell survival in the absence of Bcl-2 expression. The dierence between IL-4 stimulation and lymphokine deprivation might be related to the expression levels of Bcl-2 and/or Bcl-x, which are downregulated when cells are lymphokine-deprived, but remain at high levels when IL-2 is present (GoÂ mez et al., 1997c) . Why cell survival control is exerted through distinct mechanisms by IL-2 and IL-4 is a question that may be solved by the identi®cation of the crucial cellular mediators that drive the IL-4 receptor signals.
Materials and methods
Cells and cultures
TS1ab is a murine T cell line, stably transfected with the a and b chains of the human IL-2 receptor (Pitton et al., 1993) . The untransfected wild type line, TS1, proliferates in response to IL-4 or IL-9. TS1ab responds independently to IL-2, IL-4 or IL-9. Cells were cultured in RPMI 1640 (BioWhittaker, Walkersville, MD) supplemented with 5% heat-inactivated fetal calf serum (FCS, Gibco, Grand Island, NY), 2 mM glutamine, 10 mM HEPES, 0.55 mM arginine, 0.24 mM asparagine, 50 mM 2-mercaptoethanol and 60 U/ml IL-4 or 5 ng/ml rIL-2.
Lymphokines and antibodies
Human recombinant IL-2 was provided by HomannLaRoche (Nutley, NJ). Murine rIL-4 or culture supernatant of an HeLa subline (H28) transfected with the pKCRIL-4 neo plasmid was used as a source of murine IL-4. Rabbit polyclonal anti-Bcl-2 and mouse monoclonal antiRas antibodies were obtained from Oncogene Science (Cambridge, MA), anti-NF-ATp rabbit polyclonal antibody was obtained from UBI (Lake Placid, NY), peroxidase-conjugated goat anti-rabbit or goat anti-mouse Ig antiserum from Dako (Glostrup, Denmark), FK506 from Dr S Kanamoto (Fujisawa Pharmaceutical Co., Ibaraki, Japan) and cyclosporin A (CsA) from Merck (Darmstadt, Germany). The pCMV4-Hp55 vector was kindly provided by Dr WC Greene (Gladstone Inst. Virology and Immunology, San Francisco, CA). DEAEdextran was from Pharmacia (Uppsala, Sweden). CaptureTec pHook-3 Kit was from Invitrogene (San Diego, CA). The constitutively active CN expression vector was provided by Dr O'Keef and O'Neil and was described previously (Nature (1992) 357, 692). The 3X NF-AT/Luc vector contains three copies of the NF-AT site from IL-2 promoter (from7285 to7255) inserted in the TK Luc cassette. The dominant negative NF-AT expression vector was provided by Dr J Crabtree.
DNA probes
The following probes were used: for the NF-AT binding site, 5'-GGAAAAACTGTTTCATACAGAAG-3'; NF-kB binding site, 5'-GGTTGGGGACTTTCCAGCCG-3'; CREB binding site, 5'-GGCTCCATGACGTCATGG-3'; Oct-1 binding site, 5'-GGAAATATGTGTAATATGTAAAAC-ATT-3'; AP-1 binding site, 5'-GGCTTGATGAGTCAG-CCG-3', and the SP-1 binding site, 5'-GGATTCGA-TCGGGGCGGGGCGAGC-3'.
The mouse bcl-2 probe was an EcoRI ± HindIII 800 bp fragment and the mouse b-actin probe was a ClaI ± BamHI 600 bp fragment. Probes were labelled with 32 P-ATP.
Nuclear extracts and electrophoretic mobility shift assay Cells (1610 7 ) were resuspended for 2 min in 1 ml of Buer A (50 mM NaCl, 10 mM HEPES pH 8, 0.5 M sucrose, 1 mM EDTA, 0.5 mM spermidine, 0.15 mM spermine and 0.2% Triton X-100). Lysates were centrifuged at 6500 g for 3 min at 48C. Nuclei were resuspended in 1 ml of Buer B (50 mM NaCl, 10 mM HEPES pH 8, 25% glycerol, 0.1 mM EDTA, 0.5 mM spermidine and 0.15 mM spermine) and centrifuged (6500 g, 3 min, 48C). Nuclear proteins were extracted at 48C for 30 min in 60 ml of Buer C (350 mM NaCl, 10 mM HEPES pH 8, 25% glycerol, 0.1 mM EDTA, 0.5 mM spermidine and 0.15 mM spermine). Supernatants were cleared by centrifugation and stored at7808C. Protein concentration was determined using the Bradford Control of Bcl-2 expression by IL-2 and IL-4 J Go Â mez et al method (Bio-Rad). All buers were supplemented with protease inhibitors.
End-labelled oligonucleotides (0.2 ng) were incubated at room temperature for 15 min with 3 mg of nuclear proteins in the presence of 0.25 mg ssDNA, 60 mM KCl, 0.01% NP-40, 0.1 mg/ml BSA and 4% Ficoll. Protein-DNA complexes were separated from free probe on a 5% polyacrylamide gel in 0.56TBE (90 mM Tris, 90 mM boric acid, 1.5 mM EDTA, pH 8) at 240 V for 3 h at room temperature. Gels were dried and exposed to X-ray ®lm. For each site, a 20-fold molar excess of speci®c cold oligonucleotide was used to compete for protein binding to a radiolabelled probe.
Western blot
For extraction of total proteins, cells (2610 6 ) were lysed in Laemmli sample buer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 0.1% bromophenol blue and 10% glycerol) and protein extracts separated by SDS ± PAGE, transferred to nitrocellulose membrane, blocked with 5% non-fat dry milk in TBS (20 mM Tris-HCl pH 7.5, 150 mM NaCl) and incubated with antibody in TBS/0.5% non-fat dry milk. Membranes were washed with 0.05% Tween 20 in TBS and incubated with a peroxidase-coupled secondary antibody. After washing, labelled proteins were developed using ECL system (Amersham).
When blot stripping was required, membranes were incubated with 62.5 mM Tris-HCl pH 6.8, 2% SDS and 0.1 M 2-ME for 1 h at 568C and washed extensively with PBS before reblocking and probing.
RNA isolation
Total RNA was isolated following the method of Maniatis et al. (1989) . For Northern blot analysis, 15 mg RNA samples were electrophoresed in 1% agarose gel in the presence of formaldehyde and transferred to a nitrocellulose ®lter. After hybridization with the probe, the ®lter was washed and exposed to X-ray ®lm at7708C with an intensifying screen. The ®lter was stripped and rehybridized with a cDNA probe encoding b-actin.
Transient transfection
TS1ab cells were transiently transfected using the DEAEdextran method. Cells (10610 6 ) in exponential growth were washed with TS buer (25 mM Tris-HCl, 137 mM NaCl, 5 mM KCl, 0.7 mM CaCl 2 , 0.5 mM MgCl 2 and 0.6 mM Na 2 HPO 4 , pH 7.4). Cells were cotransfected with the plasmid pHook3 and 3X NF-AT/Luc or an irrelevant plasmid using the capture Tec pHook3 kit (Clontech). Similarly, cells were cotransfected with the plasmid pHook3 and the dominant negative NF-AT expression vector. pHook3 vector expresses a hapten-speci®c single chain antibody (sFv) on the surface of transfected cells. 2.5 mg of each plasmid, 375 ml of TS buer and 375 ml of freshly-prepared DEAE-dextran (1 mg/ml) in TS buer were mixed successively. Cells were incubated for 20 min at room temperature and 6.75 ml of RPMI/5% FCS added. Cells were incubated for 1 h at 378C, centrifuged and resuspended in 12 ml of RPMI/5% FCS supplemented with 60 U/ml of IL-4 or 5 ng/ml of IL-2. Cells expressing the sFv can be isolated from the culture by binding to haptencoated (phOX) magnetic beads. Transfected cells were selected and cells were analysed for luciferase activity or Bcl-2 expression.
Luciferase assay
Cells were transfected with the plasmid 3XNF-AT-Luc or an irrelevant plasmid (pCMV4-Hp55). After transfection, cells were stimulated with 60 U/ml of IL-4 or 5 ng/ml of IL-2 for 24 h, then washed in cold PBS and lysed in Luc buer (25 mM Tris-phosphate pH 7.8, 8 mM MgCl 2 , 1 mM DTT, 1 mM EDTA, 1% Triton X-100, 1% BSA and 15% glycerol) at 48C. Lysates were centrifuged (13 000 g, 20 min, 48C). Extracts were diluted in Luc buer and the reaction mixture prepared with 91 ml of 25 mM luciferin, 303 ml of 20 mM ATP and 4606 ml of Luc buer. Luciferase activity in protein extracts was measured using a Berthold LB9501 luminometer.
